CMMB Latest Press Releases, Chemomab Therapeutics Ltd Corporate News

Releases

1.596

-2.71%

-0.045

All
Financials
Insiders

6-K | Chemomab Therapeutics Ltd.(0001534248)
10/11/2024 12:02
UPLOAD | Chemomab Therapeutics Ltd.(0001534248)
10/04/2024 05:22
CORRESP | Chemomab Therapeutics Ltd.(0001534248)
10/04/2024 05:22
SC 13D/A | Chemomab Therapeutics Ltd.(0001534248)
09/16/2024 12:35
144 | Chemomab Therapeutics Ltd.(0001534248)
09/12/2024 12:57
424B3 | Chemomab Therapeutics Ltd.(0001534248)
09/09/2024 02:17
EFFECT | Chemomab Therapeutics Ltd.(0001534248)
09/09/2024 02:03
F-3 | Chemomab Therapeutics Ltd.(0001534248)
08/23/2024 12:09
6-K | Chemomab Therapeutics Ltd.(0001534248)
08/21/2024 03:01
SC 13G | Chemomab Therapeutics Ltd.(0001534248)
08/20/2024 10:37
6-K | Chemomab Therapeutics Ltd.(0001534248)
07/25/2024 04:11
6-K | Chemomab Therapeutics Ltd.(0001534248)
06/12/2024 12:03
6-K | Chemomab Therapeutics Ltd.(0001534248)
05/09/2024 03:02
6-K | Chemomab Therapeutics Ltd.(0001534248)
05/08/2024 03:06
6-K | Chemomab Therapeutics Ltd.(0001534248)
05/03/2024 12:04
20-F | Chemomab Therapeutics Ltd.(0001534248)
03/28/2024 02:18
SC 13D/A | Chemomab Therapeutics Ltd.(0001534248)
03/11/2024 15:20
6-K | Chemomab Therapeutics Ltd.(0001534248)
03/07/2024 02:01
6-K | Chemomab Therapeutics Ltd.(0001534248)
01/03/2024 02:01
CORRESP | Chemomab Therapeutics Ltd.(0001534248)
12/05/2023 04:55
SC 13D/A | Chemomab Therapeutics Ltd.(0001534248)
11/15/2023 11:36
6-K | Chemomab Therapeutics Ltd.(0001534248)
11/09/2023 03:01
EFFECT | Chemomab Therapeutics Ltd.(0001534248)
11/06/2023 01:07
F-3/A | Chemomab Therapeutics Ltd.(0001534248)
10/30/2023 04:34
F-3 | Chemomab Therapeutics Ltd.(0001534248)
10/16/2023 12:26
6-K | Chemomab Therapeutics Ltd.(0001534248)
08/14/2023 04:07
6-K | Chemomab Therapeutics Ltd.(0001534248)
08/08/2023 02:09
4 | Chemomab Therapeutics Ltd.(0001534248)
07/05/2023 13:50
6-K | Chemomab Therapeutics Ltd.(0001534248)
07/03/2023 11:50
4 | Chemomab Therapeutics Ltd. (0001534248)
06/20/2023 02:03
4 | Chemomab Therapeutics Ltd.(0001534248)
06/16/2023 12:04
8-K | Chemomab Therapeutics Ltd.(0001534248)
06/16/2023 12:03
3 | Chemomab Therapeutics Ltd.(0001534248)
06/05/2023 13:07
8-K | Chemomab Therapeutics Ltd.(0001534248)
06/05/2023 03:01
RW | Chemomab Therapeutics Ltd.(0001534248)
06/02/2023 12:03
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
05/19/2023 12:08
8-K | Chemomab Therapeutics Ltd.(0001534248)
05/11/2023 02:12
10-Q | Chemomab Therapeutics Ltd.(0001534248)
05/11/2023 02:09
4 | Chemomab Therapeutics Ltd.(0001534248)
03/23/2023 03:39
4 | Chemomab Therapeutics Ltd.(0001534248)
03/23/2023 03:38
4 | Chemomab Therapeutics Ltd.(0001534248)
03/23/2023 03:36
4 | Chemomab Therapeutics Ltd.(0001534248)
03/23/2023 03:34
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
03/22/2023 12:46
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
03/21/2023 12:12
10-K | Chemomab Therapeutics Ltd.(0001534248)
03/20/2023 02:24
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
02/22/2023 01:05
8-K | Chemomab Therapeutics Ltd.(0001534248)
02/21/2023 02:06
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
02/21/2023 01:21
8-K | Chemomab Therapeutics Ltd.(0001534248)
02/21/2023 01:13
S-1 | Chemomab Therapeutics Ltd.(0001534248)
01/13/2023 11:03

Webull provides the latest Chemomab Therapeutics Ltd (CMMB) stock and general news. This information may help you make smarter investment decisions.

About CMMB

Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.